Compounds and compositions as protein kinase inhibitors
The present invention provides compounds of Formula I or II:wherein R1, R1b, R2, R3, R4, R5, R6 and R7 are defined herein. The compounds of Formula (I) or (II) and pharmaceutical compositions thereof are useful for the treatment of B-Raf-associated diseases.
Novartis AG
A A A A A C A
A61K A61K A61P A61P A61P C07D A61P
inventional inventional inventional inventional inventional inventional inventional
Sabina Daniel Shenlin John Jeff Xianming Zuosheng Qiong Abran Q.
Pecchi Poon Huang Tellew Jin Liu Zhang Costales